HCPLive® Peer Exchange panel discussions feature authoritative insights, opinions, and perspectives on important issues facing today's care professionals.
April 29th 2022
Experts in cardiovascular medicine share strategies for the practical management of obstructive hypertrophic cardiomyopathy.
A panel of experts discusses use of antithrombotic therapy for treatment of polyvascular disease, in particular coronary artery disease (CAD). They also share data in patients with CAD and peripheral artery disease (PAD) with dual pathway inhibition (DPI) and their insights on optimal duration of dual antiplatelet therapy (DAPT) and rationale for switching therapy.
April 27th 2022
Linda Stein Gold, MD; Raj J. Chovatiya, MD, PhD; Eric Simpson, MD, MCR; and Alexandra K. Golant, MD, share their approaches to optimizing the treatment of atopic dermatitis with a focus on the utilization of topical and oral JAK inhibitors.
April 25th 2022
Experts in endocrinology and cardiology discuss various guideline and treatments for the management of ASCVD and hypercholesterolemia.
April 18th 2022
Nada Elbuluk, MD, MSc, FAAD, explores the clinical burden of vitiligo and examines the current and future treatment landscape in this upcoming HCPLive Peer Exchange program.
April 15th 2022
Raj J. Chovatiya, MD, PhD, shares insight on optimizing treatment for patients with atopic dermatitis and addresses unmet needs in the current treatment landscape in this upcoming HCPLive Cure Connections program.
March 31st 2022
A panel of experts explore the patient journey and unmet needs of patients with treatment resistant depression (TRD), outline treatment strategies for TRD outside of oral antidepressants/antipsychotics and explore strategies to support access to these alternative therapies through improved billing/coding strategies.
March 22nd 2022
Key opinion leaders explore the diagnosis, management, and treatment of attention deficit hyperactivity disorder (ADHD) in the adult population and share key insights on the evolving treatment landscape.
March 11th 2022
A panel of experts discuss the diagnosis, management, and treatment options for peripheral artery disease (PAD), as well as what can be done to improve the treatment landscape.
Expert panelists reflect on the selection and use of recently approved treatments, including interleukin pathway inhibitors, for type 2 inflammation in atopic dermatitis.
Carolyn Rowley, PhD, Addresses Mental Health and Wellness in People with Sickle Cell Disease
David Au, MD, MS: Lifestyle Interventions for Weight Loss in Obese Patients with COPD
Claims-Based Algorithm Identifies PAH 6 Months Prior to Diagnosis